Everest Medicines has announced the commercial launch of VELSIPITY (etrasimod arginine tablets) in Mainland China, marking a significant milestone in the treatment of ulcerative colitis (UC). The drug's debut was highlighted by the issuance of the first prescription at The First Affiliated Hospital of Sun Yat-sen University. On its launch day, VELSIPITY was prescribed in eight tertiary hospitals across seven […]















